Stepan Company

Fundamentals7.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Low profitability
  • Positive operating cash
  • High payout ratio

AI
AI Summary

6.0

SCL's investment case has shifted from a pure value/recovery play to an execution-driven re‑rating where meaningful upside now hinges on a successful Pasadena ramp, sustained specialty sales, and normalization of oleochemical feedstock costs rather than a simple cyclical rebound; watch for stabilization above the $44.8 support and demonstrable FCF expansion/capex taper as the concrete triggers to move from “watch” to “buy.” Key downside is feedstock volatility or missed Pasadena execution—either would quickly erode margins and force a negative rerating.

Execution
FeedstockRisk
Watchlist‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Low profitability
  • Positive operating cash
  • High payout ratio

SCL shows weak profitability and ROE with modest operating cash generation and manageable leverage, but a high payout and meaningful capex constrain retained cash and make earnings vulnerability a key risk.

PositiveCashflow
HighPayout

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Strong downtrend
  • Elevated volatility
  • Resistance cluster

SCL is in a clear downtrend over the last month, sliding roughly 33% from $66.71 to $44.84 with immediate support at $44.84 and resistance in the $50.00–$53.11 band, so look for a sustained close below $44.84 to confirm further downside or a break back above $50–$53 to signal stabilization or relief.

bearish
watch
Support Level: $44.84
Resistance Level: $50.00–$53.11

Rapid ~33% decline from $66.71 to $44.84 over the last month indicating elevated volatility

Sentiment & News

6.0

Key News Insights:

  • Operational recovery
  • Earnings surprise
  • Valuation trimmed

Stepan missed Q4 earnings with a surprise loss and a sharp share gap down, but showed early operational recovery (EBITDA growth, debt reduction, positive FCF) while analysts trim upside amid a reduced fair value and maintained dividend.

Recovery
EarningsMiss

Short-term downside pressure likely after the surprise loss and rerating, but improving cash flow and reduced leverage support a medium-term recovery narrative